CIK 0001746473
- Non-accelerated filer
- Smaller reporting company
PLIANT THERAPEUTICS, INC.
Sign in to watch- Ticker
- PLRX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 474272481
- Phone
- +1 650-481-6770
- Business address
- 331 OYSTER POINT BOULEVARD, SOUTH SAN FRANCISCO, CA, 94080
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2022-11-29 | Third Rock Ventures III, L.P. 10% owner | Other disposition | −2,000,000 | 1,839,160 | ||
| 2022-10-25 | Lefebvre Eric Chief Medical Officer | Sale | −5,000 | $25.05 | $125K | 133,437 |
| 2022-09-20 | Third Rock Ventures III, L.P. 10% owner | Other disposition | −2,000,000 | 3,839,160 | ||
| 2022-09-14 | Knobil Katharine Director | Grant or award · Stock Option (Right to Buy) | +30,000 | 30,000 | ||
| 2022-09-12 | Coulie Bernard President and CEO | Exercise or conversion | +12,502 | $2.08 | $26K | 71,775 |
| 2022-09-12 | Coulie Bernard President and CEO | Sale | −12,502 | $22.54 | $282K | 59,273 |
| 2022-09-12 | Coulie Bernard President and CEO | Exercise or conversion · Stock Option (right to buy) | −12,502 | 297,380 | ||
| 2022-07-12 | Coulie Bernard President and CEO | Exercise or conversion | +12,498 | $2.08 | $26K | 71,771 |
| 2022-07-12 | Coulie Bernard President and CEO | Sale | −12,498 | $22.50 | $281K | 59,273 |
| 2022-07-12 | Coulie Bernard President and CEO | Exercise or conversion · Stock Option (right to buy) | −12,498 | 309,882 | ||
| 2022-07-11 | Lefebvre Eric Chief Medical Officer | Sale | −3,000 | $20.00 | $60K | 138,436 |
| 2022-07-11 | Coulie Bernard President and CEO | Exercise or conversion | +15,000 | $2.08 | $31K | 74,273 |
| 2022-07-11 | Coulie Bernard President and CEO | Sale | −15,000 | $22.50 | $338K | 59,273 |
| 2022-07-11 | Coulie Bernard President and CEO | Exercise or conversion · Stock Option (right to buy) | −15,000 | 322,380 | ||
| 2022-06-16 | PYOTT DAVID E I Director | Grant or award · Stock Option (right to buy) | +15,000 | 15,000 | ||
| 2022-06-16 | Huh Hoyoung Director | Grant or award · Stock Option (right to buy) | +15,000 | 15,000 | ||
| 2022-06-16 | Exter Neil Director | Grant or award · Stock Option (right to buy) | +15,000 | 15,000 | ||
| 2022-06-16 | Curnutte John T Director | Grant or award · Stock Option (right to buy) | +15,000 | 15,000 | ||
| 2022-06-16 | CROWELL GAYLE A Director | Grant or award · Stock Option (right to buy) | +15,000 | 15,000 | ||
| 2022-06-16 | Bruhn Suzanne Louise Director | Grant or award · Stock Option (right to buy) | +15,000 | 15,000 |
Page 14 of 19 · 379 trades